INCYTE CORP's zilurgisertib — FDA decision expected September 26, 2026.
Run-up into the PDUFA
Daily close so far, T-120 through today. High $118.52, low $92.24. Run-up to date +21.9%. Decision 9/26/26. Historical price action, not a forecast.
Key facts
PDUFA date2026-09-26
Business days away56
Drug / candidatezilurgisertib
Indication—
CompanyINCYTE CORP
Market-cap tier—
Cohort decision-day move (history)±2% median
Cohort move is the historical median absolute decision-day move for this market-cap tier — history, not a prediction. See the full 2026 PDUFA calendar →